Invention Grant
- Patent Title: Application of PDCD4 as a therapeutic target for antidepressants and/or anxiolytics drugs
-
Application No.: US16487934Application Date: 2017-04-07
-
Publication No.: US11320440B2Publication Date: 2022-05-03
- Inventor: Lining Zhang , Yuan Li , Qun Wang , Chun Guo , Faliang Zhu
- Applicant: SHANDONG UNIVERSITY
- Applicant Address: CN Shandong
- Assignee: SHANDONG UNIVERSITY
- Current Assignee: SHANDONG UNIVERSITY
- Current Assignee Address: CN Shandong
- Agency: Oliff PLC
- Priority: CN201710097181.8 20170222
- International Application: PCT/CN2017/079746 WO 20170407
- International Announcement: WO2018/152937 WO 20180830
- Main IPC: C12N15/11
- IPC: C12N15/11 ; G01N33/68 ; C12N15/113 ; C12Q1/6883 ; A61K45/06 ; C07K16/24

Abstract:
The application of PDCD4 as a drug treatment target for anti-depression and/or anti-anxiety disorders has been proved by experimental research that the increase of PDCD4 is an important factor leading to depression in the process of stress; PDCD4 as a target to inhibit its expression or function can play a good antidepressant role, and has no effect on normal physiological state. Therefore, PDCD4 can be used as a target in the preparation and screening of antidepressant and/or anxiolytic drugs, which has a broad application prospect.
Public/Granted literature
- US20200049717A1 APPLICATION OF PDCD4 AS A THERAPEUTIC TARGET FOR ANTIDEPRESSANTS AND/OR ANXIOLYTICS DRUGS Public/Granted day:2020-02-13
Information query
IPC分类: